WuXi AppTec Celebrated for Sustainability Achievements
WuXi AppTec, a prominent global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), has proudly received the double "A List" rating from CDP, highlighting its leadership in corporate transparency and performance in both Climate Change and Water Security. This esteemed recognition, which represents the highest rating available from CDP, reflects WuXi AppTec's strong dedication to sustainable environmental practices and effective water resource management.
Understanding CDP's Role
CDP stands as a vital global non-profit organization that administers the only independent environmental disclosure platform available worldwide. It encourages entities—ranging from corporations to cities—to transparently account for and manage their environmental impact, driving towards a more sustainable future. Each year, CDP evaluates thousands of companies based on their environmental strategies, creating a benchmark revered across various sectors. WuXi AppTec has now earned a spot on the CDP's "A List" for Climate Change for the first time, while maintaining its presence on the "A List" for Water Security for a second consecutive year.
Commitment to Environmental Stewardship
Dr. Steve Yang, Co-CEO of WuXi AppTec, expressed that this double "A" rating from CDP tokenizes the company's commitment to integrating sustainability within its pharmaceutical innovations. He emphasized, "As a proven partner in the pharmaceuticals and life sciences industries, we strive to develop essential therapies while maintaining a strong focus on environmental stewardship throughout our operations." WuXi AppTec has instituted various strategies for climate change and water management, emphasizing the importance of aligning business practices with environmental goals.
These strategies form the backbone of WuXi AppTec's proactive stance on environmental protection. The company continuously assesses potential environmental risks and opportunities, refining its management systems to strengthen their operational practices. The commitment includes setting measurable targets across critical environmental management areas which allow the company to monitor progress and undergo thorough reviews regularly.
Integrating Sustainability Across Operations
As a pivotal driver for innovation in the pharmaceutical space, WuXi AppTec's integration of sustainability is imperative. This practice resonates with the values held by the company's partners and clients, further showcasing its leadership in this important area. Recognition from diverse prestigious organizations speaks to this commitment; for five years in a row, WuXi AppTec achieved the MSCI ESG Leadership Rating. Furthermore, they recently secured an AAA rating, underscoring their ongoing dedication to sustainability.
Beyond this, WuXi AppTec has been acknowledged consistently on the Dow Jones Sustainability Index (DJSI) for four years and included in the FTSE4Good Index Series for three years. The EcoVadis awarded the company a Gold Medal in sustainability, marking two years of such recognition.
Future Goals and Partnerships
WuXi AppTec's sustainability commitments continue to expand, evidenced by the validation received from the Science Based Targets initiative (SBTi) for its short-term emissions reduction objectives. Moreover, the company actively participates in the United Nations Global Compact (UNGC), making strides in alignment with its ten principles. It is also a key supplier partner in the Pharmaceutical Supply Chain Initiative (PSCI).
About WuXi AppTec
WuXi AppTec is recognized as a trusted partner and contributor within the pharmaceutical and life sciences sectors, extending R&D and manufacturing services that propel healthcare innovation. With operational footprints spanning Asia, Europe, and North America, the company showcases its unique CRDMO (Contract Research, Development, and Manufacturing Organization) platform, catering to diverse client needs. Currently, WuXi AppTec collaborates with nearly 6,000 partners across more than 30 countries, working hand-in-hand to facilitate advanced therapeutic developments. Fuelled by the belief that every drug can be crafted and every disease attended to, WuXi AppTec remains steadfast in its mission: advancing breakthrough treatments—one partnership at a time.
Frequently Asked Questions
What recognition has WuXi AppTec recently received?
WuXi AppTec has been awarded a double "A List" rating from CDP for leadership in Climate Change and Water Security.
What is the significance of CDP's rating?
CDP's rating is a prestigious acknowledgment of a company’s commitment to environmental activities and sustainability practices.
Why is WuXi AppTec’s sustainability commitment important?
It highlights the company’s dedication to integrating environmental protection with innovative pharmaceutical development, benefitting both the industry and the planet.
How does WuXi AppTec support global sustainability initiatives?
WuXi AppTec is a participant in the United Nations Global Compact and the Pharmaceutical Supply Chain Initiative, demonstrating its commitment to global sustainability efforts.
What future goals does WuXi AppTec have regarding sustainability?
The company aims to reduce emissions through validated targets and continue integrating sustainability across its operations, ensuring ongoing improvements in environmental management.
